|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ASPIRIN CAN DISPLACE WARFARIN FROM PROTEIN BINDING SITES, LEADING TO A PROLONGATION OF BOTH THE PROTHROMBIN TIME AND THE BLEEDING TIME
|
CO-ADMINISTRATION MAY BE ASSOCIATED WITH INCREASED RISK OF BLEEDING
|
ALCOHOL HAS VARIABLE EFFECT ON ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
CONCOMITANT USE WITH ORAL ANTICOAGULANTS MAY INCREASE THE RISK OF BLEEDING
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ASPIRIN CAN DISPLACE WARFARIN FROM PROTEIN BINDING SITES, LEADING TO A PROLONGATION OF BOTH THE PROTHROMBIN TIME AND THE BLEEDING TIME
|
WHILE STUDIES HAVE NOT SHOWN INTERACTIONS WITH ORAL ANTICOAGULANTS, CONCURRENT THERAPY REQUIRES CLOSE MONITORING OF PATIENTS FOR POTENTIAL MODIFICATION IN ANTICOAGULANTS DOSAGE
|
WHILE STUDIES HAVE NOT SHOWN INTERACTIONS WITH ORAL ANTICOAGULANTS, CONCURRENT THERAPY REQUIRES CLOSE MONITORING OF PATIENTS FOR POTENTIAL MODIFICATION IN ANTICOAGULANTS DOSAGE
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
DEPRESSED PLASMA PROTHROMBIN ACTIVITY ; MAY REQUIRE DOWNWARD ADJUSTMENT OF THE ANTICOAGULANT DOSAGE
|
DEPRESSED PLASMA PROTHROMBIN ACTIVITY ; MAY REQUIRE DOWNWARD ADJUSTMENT OF THE ANTICOAGULANT DOSAGE
|
CONCOMITANT USE WITH ORAL ANTICOAGULANTS MAY INCREASE THE RISK OF BLEEDING
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ALCOHOL HAS VARIABLE EFFECT ON ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
BEZAFIBRATE POTENTIATES THE ACTION OF THE DRUG
|
BEZAFIBRATE POTENTIATES THE ACTION OF THE DRUG
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
CARBAMAZEPINE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED PROTHROMBIN TIME, WITH OR WITHOUT CLINICAL BLEEDING
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
CO-ADMINISTRATION IN PREDOMINANTLY ELDERLY PATIENTS HAS RESULTED IN INCREASES IN PROTHROMBIN TIME AND BLEEDING
|
CHLORAMBUCIL EFFECT IS POTENTIATED BY THE DRUG
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTICOAGULANT EFFECT IS REDUCED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ASPIRIN CAN DISPLACE WARFARIN FROM PROTEIN BINDING SITES, LEADING TO A PROLONGATION OF BOTH THE PROTHROMBIN TIME AND THE BLEEDING TIME
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
ANTICOAGULANT EFFECT IS REDUCED
|
COUMARINE DERIVATIVES MAY ENHANCE THE ACTIVITY OF THE DRUG AND HENCE TOXICITY
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
WHILE STUDIES HAVE NOT SHOWN INTERACTIONS WITH ORAL ANTICOAGULANTS, CONCURRENT THERAPY REQUIRES CLOSE MONITORING OF PATIENTS FOR POTENTIAL MODIFICATION IN ANTICOAGULANTS DOSAGE
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
WHILE STUDIES HAVE NOT SHOWN INTERACTIONS WITH ORAL ANTICOAGULANTS, CONCURRENT THERAPY REQUIRES CLOSE MONITORING OF PATIENTS FOR POTENTIAL MODIFICATION IN ANTICOAGULANTS DOSAGE
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
|
ASPIRIN CAN DISPLACE WARFARIN FROM PROTEIN BINDING SITES, LEADING TO A PROLONGATION OF BOTH THE PROTHROMBIN TIME AND THE BLEEDING TIME
|
ASPIRIN CAN DISPLACE WARFARIN FROM PROTEIN BINDING SITES, LEADING TO A PROLONGATION OF BOTH THE PROTHROMBIN TIME AND THE BLEEDING TIME
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
CO-ADMINISTRATION HAS RESULTED IN BLEEDING AND/OR INCREASED PROTHROMBIN TIME IN FEW PATIENTS
|
ASPIRIN CAN DISPLACE WARFARIN FROM PROTEIN BINDING SITES, LEADING TO A PROLONGATION OF BOTH THE PROTHROMBIN TIME AND THE BLEEDING TIME
|
ENHANCED EFFECTS OF ANTICOAGULANT
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS REDUCED
|
CO-ADMINISTRATION MAY BE ASSOCIATED WITH INCREASED RISK OF BLEEDING
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|